Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FES-PET to predict estradiol response in anti-hormonal resistant breast cancer
NL-OMON26431Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2010
- Countries
- 1
01
Overview
Open-label, single-arm trial of estradiol in breast cancer, sponsored by University Medical Center Groningen. Primary endpoint: Predictive performance of FES-PET SUV for response to estrogen therapy. Started Feb 2010; status: recruiting.
02
Drugs
estradiol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON26431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26431.